Drug
Fosinopril
Fosinopril is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
33%
Ph not_applicable
1
17%
Ph phase_4
2
33%
Ph phase_3
1
17%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)
Trials by Status
unknown117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_3
Prevention of Renal and Vascular Endstage Disease Intervention Trial
NCT03073018
completedphase_2
ACE Inhibition and Novel Cardiovascular Risk Factors
NCT00051389
unknownphase_4
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
NCT02646397
completedphase_4
Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)
NCT01014338
completedphase_2
Eplerenone, ACE Inhibition and Albuminuria
NCT00315016
Clinical Trials (6)
Showing 6 of 6 trials
NCT03073018Phase 3
Prevention of Renal and Vascular Endstage Disease Intervention Trial
NCT00051389Phase 2
ACE Inhibition and Novel Cardiovascular Risk Factors
NCT02646397Phase 4
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension
NCT01014338Phase 4
Angiotensin-converting Enzyme (ACE)-Inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease (COPD)
NCT00315016Phase 2
Eplerenone, ACE Inhibition and Albuminuria
NCT01342614Not Applicable
The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6